AbbVie (ABBV) EBT Margin (2012 - 2026)

AbbVie (ABBV) reported EBT Margin of 6.93% for Q1 2026, down 552.0% year-over-year from 1.53% in Q1 2025, and down 56.86% quarter-over-quarter from 16.05% in Q4 2025.

AbbVie (ABBV) EBT Margin (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has 15 years of EBT Margin data on file, last reported at 6.93% in Q1 2026.

  • EBT Margin for Q1 2026 came in at 6.93%, down 552.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 9.51% (up 320.0% YoY), and the FY2025 annual result was 10.79%, up 419.0% from the prior year.
  • EBT Margin fell to 6.93% in Q1 2026 per ABBV's latest filing, from 16.05% in the prior quarter.
  • Over five years, EBT Margin peaked at 36.41% in Q1 2022 and troughed at 15.02% in Q4 2024.
  • A 5-year average of 12.8% and a median of 14.02% in 2023 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2023 and 2025: EBT Margin sank 3252 bps in 2023, then soared 3108 bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 19.61% in 2022, then slumped by 57 bps to 8.47% in 2023, then plunged by 277 bps to 15.02% in 2024, then surged by 207 bps to 16.05% in 2025, then sank by 57 bps to 6.93% in 2026.
  • Business Quant data shows ABBV's EBT Margin at 6.93% in Q1 2026, 16.05% in Q4 2025, and 4.53% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 28.10%
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 44.70%
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 24.89%
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 6.93%
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -21.49%
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 24.18%
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 37.07%
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 135.53%
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 28.20%
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.93%
Dec 31, 2025 16.05%
Sep 30, 2025 4.53%
Jun 30, 2025 10.08%
Mar 31, 2025 12.45%
Dec 31, 2024 -15.02%
Sep 30, 2024 14.41%
Jun 30, 2024 14.84%
Mar 31, 2024 14.26%
Dec 31, 2023 8.47%
Sep 30, 2023 14.02%
Jun 30, 2023 18.82%
Mar 31, 2023 3.89%
Dec 31, 2022 19.61%
Sep 30, 2022 29.71%
Jun 30, 2022 8.11%
Mar 31, 2022 36.41%
Dec 31, 2021 28.69%
Sep 30, 2021 25.71%
Jun 30, 2021 8.33%